Episode 4 of Supply Chain Signal examines PhRMA’s legal challenge to CMS ’ GLOBE model and whether manufacturers can lower costs, expand U.S. production and strengthen supply chain resilience all at once.
|Articles|September 1, 2022
Take the Direct Route to Commercialization in Canada
Author(s)Innomar Strategies
Advertisement
In addition to being among the top 10 pharmaceutical markets in the world, Sandra Anderson, Senior Vice President, Commercialization and Strategy, discusses why the Canadian pharmaceutical sector has a growing presence and what makes it so attractive to manufacturers.
Not only does Innomar Strategies provide strategic advice and planning, but we also execute and implement all end-to-end commercialization services for companies launching a new therapy into the Canadian marketplace.
Advertisement
Related to this article
Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy before chasing use cases.
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior authorization for self-funded health plans and FDA finalizes its guidance on prescription drug apps and software.
CSafe's Aaron Mantia explains how lane, temperature range, duration and product cost shape thermal protection choices for bulk air cargo.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.
PAXAFE's Mark Talens explains why real-time visibility starts with process redesign and how it speeds cold chain disposition decisions.
FDA’s final guidance on prescription drug use-related software clarifies when companion app content is labeling, promotion or belongs in the PI.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Inside the 340B Rebate Pilot Standoff: Court, Congress, Drugmakers
2
Supply Chain Signal: PhRMA’s GLOBE Lawsuit and the New Economics of Pharma Supply Chains
3
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion
4
How Pharma Automation Cuts Human Touches and Error Risk
5